The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival-Reference-Cited by-同舟云学术

The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival

Published:2010-11-08 Issue:6 Volume:117 Page:1220-1226
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cantrell Leigh A.,Westin Shannon N.,Van Le Linda

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25590/fullpdf

Reference26 articles.

1. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature;Ross;Clin Ther.,2006

2. Erythropoietin for patients with malignant disease [serial online];Bohlius;Cochrane Database Syst Rev.,2004

3. Erythropoietin or darbepoetin for patients with cancer [serial online];Bohlius;Cochrane Database Syst Rev.,2006

4. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy;Crawford;Cancer.,2002

5. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer a meta-analysis of randomized trials;Bohlius;Lancet.,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of erythropoietin‐stimulating agent use during front‐line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study;International Journal of Gynecology & Obstetrics;2024-04-29

2. Network pharmacology-based approach to understand the effect and mechanism of Danshen against anemia;Journal of Ethnopharmacology;2022-01

3. Bone Marrow Toxicity: Red Blood Cells;Side Effects of Medical Cancer Therapy;2018

4. HSC Niche;Biology and Engineering of Stem Cell Niches;2017

5. Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With Chemotherapy;International Journal of Gynecologic Cancer;2016-01